These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 20105316)
1. Levetiracetam attenuates hippocampal expression of synaptic plasticity-related immediate early and late response genes in amygdala-kindled rats. Christensen KV; Leffers H; Watson WP; Sánchez C; Kallunki P; Egebjerg J BMC Neurosci; 2010 Jan; 11():9. PubMed ID: 20105316 [TBL] [Abstract][Full Text] [Related]
2. Effects of Nefiracetam, a novel pyrrolidone-type nootropic agent, on the amygdala-kindled seizures in rats. Kitano Y; Komiyama C; Makino M; Kasai Y; Takasuna K; Kinoshita M; Yamazaki O; Takazawa A; Yamauchi T; Sakurada S Epilepsia; 2005 Oct; 46(10):1561-8. PubMed ID: 16190926 [TBL] [Abstract][Full Text] [Related]
3. Levetiracetam prevents changes in levels of brain-derived neurotrophic factor and neuropeptide Y mRNA and of Y1- and Y5-like receptors in the hippocampus of rats undergoing amygdala kindling: implications for antiepileptogenic and mood-stabilizing properties. Husum H; Bolwig TG; Sánchez C; Mathé AA; Hansen SL Epilepsy Behav; 2004 Apr; 5(2):204-15. PubMed ID: 15123022 [TBL] [Abstract][Full Text] [Related]
4. The antiepileptic drug levetiracetam selectively modifies kindling-induced alterations in gene expression in the temporal lobe of rats. Gu J; Lynch BA; Anderson D; Klitgaard H; Lu S; Elashoff M; Ebert U; Potschka H; Löscher W Eur J Neurosci; 2004 Jan; 19(2):334-45. PubMed ID: 14725628 [TBL] [Abstract][Full Text] [Related]
5. Anti-convulsive and anti-epileptic properties of brivaracetam (ucb 34714), a high-affinity ligand for the synaptic vesicle protein, SV2A. Matagne A; Margineanu DG; Kenda B; Michel P; Klitgaard H Br J Pharmacol; 2008 Aug; 154(8):1662-71. PubMed ID: 18500360 [TBL] [Abstract][Full Text] [Related]
6. mRNA expression of activity-regulated cytoskeleton-associated protein (arc) in the amygdala-kindled rats. Akiyama K; Ishikawa M; Saito A Brain Res; 2008 Jan; 1189():236-46. PubMed ID: 18062938 [TBL] [Abstract][Full Text] [Related]
7. The usefulness of olfactory bulb kindling as a model for evaluation of antiepileptics. Fujiwara A; Watanabe Y; Takechi K; Ishikawa T; Kaida Y; Akagi M; Kamei C Epilepsia; 2010 Mar; 51(3):445-53. PubMed ID: 19845738 [TBL] [Abstract][Full Text] [Related]
8. Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy. Klitgaard H; Matagne A; Gobert J; Wülfert E Eur J Pharmacol; 1998 Jul; 353(2-3):191-206. PubMed ID: 9726649 [TBL] [Abstract][Full Text] [Related]
10. Levetiracetam inhibits kindling-induced synaptic potentiation in the dentate gyrus of freely moving rats. Sugaya Y; Jinde S; Kato N; Maru E Neurosci Res; 2010 Feb; 66(2):228-31. PubMed ID: 19896989 [TBL] [Abstract][Full Text] [Related]
11. Antiepileptogenic effects of the novel anticonvulsant levetiracetam (ucb L059) in the kindling model of temporal lobe epilepsy. Löscher W; Hönack D; Rundfeldt C J Pharmacol Exp Ther; 1998 Feb; 284(2):474-9. PubMed ID: 9454787 [TBL] [Abstract][Full Text] [Related]
12. Effects of lamotrigine and levetiracetam on seizure development in a rat amygdala kindling model. Stratton SC; Large CH; Cox B; Davies G; Hagan RM Epilepsy Res; 2003 Feb; 53(1-2):95-106. PubMed ID: 12576171 [TBL] [Abstract][Full Text] [Related]
13. Unidirectional cross-tolerance from levetiracetam to carbamazepine in amygdala-kindled seizures. Zhang ZJ; Xing GQ; Russell S; Obeng K; Post RM Epilepsia; 2003 Dec; 44(12):1487-93. PubMed ID: 14636317 [TBL] [Abstract][Full Text] [Related]
14. Activin mRNA induced during amygdala kindling shows a spatiotemporal progression that tracks the spread of seizures. Foster JA; Puchowicz MJ; McIntyre DC; Herkenham M J Comp Neurol; 2004 Aug; 476(1):91-102. PubMed ID: 15236469 [TBL] [Abstract][Full Text] [Related]
15. Differences in the anatomic distribution of immediate-early gene expression in amygdala and angular bundle kindling development. Hosford DA; Simonato M; Cao Z; Garcia-Cairasco N; Silver JM; Butler L; Shin C; McNamara JO J Neurosci; 1995 Mar; 15(3 Pt 2):2513-23. PubMed ID: 7891185 [TBL] [Abstract][Full Text] [Related]
16. Effects of levetiracetam on hippocampal kindling in Noda epileptic rats. Ishimaru Y; Chiba S; Serikawa T; Sasa M; Inaba H; Tamura Y; Ishimoto T; Takasaki H; Sakamoto K; Yamaguchi K Brain Res; 2010 Jan; 1309():104-9. PubMed ID: 19879253 [TBL] [Abstract][Full Text] [Related]
17. Development of tolerance during chronic treatment of kindled rats with the novel antiepileptic drug levetiracetam. Löscher W; Hönack D Epilepsia; 2000 Dec; 41(12):1499-506. PubMed ID: 11114206 [TBL] [Abstract][Full Text] [Related]
18. Omega 3 polyunsaturated fatty acids enhance the protective effect of levetiracetam against seizures, cognitive impairment and hippocampal oxidative DNA damage in young kindled rats. Abdel-Wahab BA; Shaikh IA; Khateeb MM; Habeeb SM Pharmacol Biochem Behav; 2015 Aug; 135():105-13. PubMed ID: 26044965 [TBL] [Abstract][Full Text] [Related]
19. The effect of neuropeptide FF in the amygdala kindling model. Buffel I; Meurs A; Portelli J; Raedt R; De Herdt V; Poppe L; De Meulenaere V; Wadman W; Bihel F; Schmitt M; Vonck K; Bourguignon JJ; Simonin F; Smolders I; Boon P Acta Neurol Scand; 2016 Sep; 134(3):181-8. PubMed ID: 26503695 [TBL] [Abstract][Full Text] [Related]
20. Levetiracetam: the preclinical profile of a new class of antiepileptic drugs? Klitgaard H Epilepsia; 2001; 42 Suppl 4():13-8. PubMed ID: 11564119 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]